000 01474 a2200445 4500
005 20250517043838.0
264 0 _c20160804
008 201608s 0 0 eng d
022 _a1936-0541
024 7 _a10.1007/s12072-015-9651-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTong, Myron John
245 0 0 _aPredicting clinical outcomes in patients with HBsAg-positive chronic hepatitis.
_h[electronic resource]
260 _bHepatology international
_cOct 2015
300 _a567-77 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aDNA, Viral
_xanalysis
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aForecasting
650 0 4 _aHepatitis B Surface Antigens
_ximmunology
650 0 4 _aHepatitis B virus
_xgenetics
650 0 4 _aHepatitis B, Chronic
_xcomplications
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xblood
650 0 4 _aMale
650 0 4 _aProspective Studies
650 0 4 _aalpha-Fetoproteins
_xmetabolism
700 1 _aHuynh, Thatcher Thi
700 1 _aSiripongsakun, Surachate
700 1 _aChang, Patrick Weijen
700 1 _aTong, Lori Terese
700 1 _aHa, Yen Phi
700 1 _aMena, Edward Alphonso
700 1 _aWeissman, Matthew Frank
773 0 _tHepatology international
_gvol. 9
_gno. 4
_gp. 567-77
856 4 0 _uhttps://doi.org/10.1007/s12072-015-9651-z
_zAvailable from publisher's website
999 _c25117739
_d25117739